| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
9,258 |
2,961 |
$93K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,033 |
4,433 |
$69K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,798 |
6,166 |
$65K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,573 |
1,130 |
$52K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,429 |
4,072 |
$50K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14,805 |
4,736 |
$37K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,237 |
3,447 |
$37K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,230 |
2,457 |
$28K |
| G0378 |
Hospital observation service, per hour |
2,485 |
1,607 |
$17K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
14,846 |
4,559 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,744 |
2,229 |
$13K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,783 |
1,289 |
$12K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,088 |
1,974 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,621 |
3,885 |
$11K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
974 |
876 |
$11K |
| 80053 |
Comprehensive metabolic panel |
18,406 |
14,013 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,495 |
4,696 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,044 |
4,088 |
$9K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,673 |
6,689 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,858 |
14,924 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,454 |
4,192 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
2,823 |
1,981 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,706 |
1,325 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,169 |
1,098 |
$6K |
| 81001 |
|
9,121 |
7,156 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,268 |
1,009 |
$5K |
| J3490 |
Unclassified drugs |
4,540 |
1,896 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,135 |
4,967 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
2,584 |
1,758 |
$4K |
| 97162 |
|
1,301 |
1,200 |
$4K |
| 80050 |
General health panel |
2,199 |
2,092 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,873 |
1,358 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,737 |
4,013 |
$3K |
| 87088 |
|
4,144 |
3,597 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
132 |
102 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
17,514 |
12,681 |
$3K |
| 83605 |
|
5,236 |
3,684 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
837 |
574 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,251 |
2,156 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,233 |
2,139 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
885 |
839 |
$2K |
| 86140 |
|
5,542 |
4,245 |
$2K |
| 81025 |
|
1,680 |
1,472 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,592 |
1,171 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,991 |
2,445 |
$2K |
| 83690 |
|
3,817 |
2,996 |
$2K |
| 96376 |
|
1,940 |
1,262 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,439 |
1,804 |
$2K |
| 87186 |
|
2,277 |
1,987 |
$2K |
| 87040 |
|
3,346 |
1,358 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,386 |
3,984 |
$2K |
| 97161 |
|
349 |
326 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,775 |
3,409 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
451 |
380 |
$2K |
| 84703 |
|
1,288 |
1,143 |
$1K |
| 73630 |
|
309 |
259 |
$1K |
| 84145 |
|
2,811 |
2,080 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,058 |
2,357 |
$1K |
| 82977 |
|
787 |
686 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
825 |
388 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
873 |
855 |
$1K |
| 85651 |
|
2,376 |
2,018 |
$922.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
580 |
407 |
$905.61 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,706 |
1,411 |
$856.36 |
| 87420 |
|
255 |
244 |
$783.02 |
| 74022 |
|
188 |
130 |
$677.06 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,059 |
1,016 |
$634.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,775 |
1,173 |
$611.69 |
| 87400 |
|
84 |
73 |
$533.70 |
| 84478 |
|
548 |
479 |
$516.79 |
| 83550 |
|
609 |
587 |
$439.34 |
| 84439 |
|
873 |
822 |
$437.58 |
| A9270 |
Non-covered item or service |
11,180 |
4,581 |
$431.08 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,276 |
2,135 |
$418.83 |
| 83540 |
|
649 |
623 |
$412.13 |
| 80061 |
Lipid panel |
3,547 |
3,423 |
$406.75 |
| 73610 |
|
246 |
205 |
$398.33 |
| 82150 |
|
688 |
549 |
$353.33 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
67 |
55 |
$349.57 |
| 73130 |
|
141 |
123 |
$303.70 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,521 |
771 |
$288.11 |
| 85610 |
|
2,624 |
1,969 |
$281.16 |
| 87070 |
|
438 |
404 |
$270.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,136 |
770 |
$256.64 |
| 84480 |
|
254 |
240 |
$234.38 |
| 82962 |
|
2,050 |
1,012 |
$233.87 |
| 90715 |
|
19 |
17 |
$231.49 |
| 83880 |
|
742 |
520 |
$229.22 |
| 73030 |
|
69 |
50 |
$228.15 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
30 |
28 |
$199.43 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
158 |
154 |
$196.58 |
| 86141 |
|
509 |
415 |
$190.79 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
849 |
544 |
$189.53 |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
351 |
85 |
$180.18 |
| 97168 |
|
12 |
12 |
$170.88 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
294 |
221 |
$145.38 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
2,759 |
1,074 |
$144.62 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
194 |
142 |
$134.39 |
| 86803 |
|
393 |
373 |
$119.95 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
120 |
90 |
$117.18 |
| 85027 |
|
234 |
208 |
$111.89 |
| 82728 |
|
268 |
240 |
$106.00 |
| 84484 |
|
3,073 |
2,023 |
$102.47 |
| 94760 |
|
1,124 |
748 |
$79.65 |
| J2060 |
Injection, lorazepam, 2 mg |
1,018 |
708 |
$78.71 |
| 86308 |
|
26 |
25 |
$62.67 |
| 87081 |
|
347 |
312 |
$55.74 |
| 73562 |
|
106 |
69 |
$55.26 |
| 86780 |
|
154 |
142 |
$43.81 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
48 |
41 |
$41.13 |
| 83735 |
|
969 |
785 |
$39.09 |
| 86677 |
|
12 |
12 |
$37.40 |
| 82607 |
|
283 |
273 |
$29.32 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,008 |
1,950 |
$27.96 |
| 85730 |
|
234 |
170 |
$23.36 |
| 97035 |
|
97 |
51 |
$18.09 |
| 82570 |
|
142 |
124 |
$13.35 |
| 82550 |
|
360 |
263 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
842 |
467 |
$0.00 |
| 85379 |
|
442 |
328 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$0.00 |
| 82553 |
|
203 |
142 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
217 |
204 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
15 |
$0.00 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
24 |
24 |
$0.00 |
| 82043 |
|
13 |
12 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
43 |
41 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
18 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
21 |
16 |
$0.00 |
| 80055 |
|
61 |
60 |
$0.00 |
| 82746 |
|
38 |
37 |
$0.00 |
| 86901 |
|
31 |
24 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
94 |
62 |
$0.00 |
| 86850 |
|
19 |
12 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
27 |
27 |
$0.00 |
| 90686 |
|
15 |
15 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
20 |
12 |
$0.00 |
| 87077 |
|
17 |
14 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
13 |
12 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
21 |
13 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
14 |
12 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
359 |
319 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17 |
17 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
145 |
140 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
17 |
$0.00 |
| 73110 |
|
35 |
31 |
$0.00 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$0.00 |
| 76000 |
|
13 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
21 |
13 |
$0.00 |
| 81003 |
|
122 |
106 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
50 |
39 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
120 |
68 |
$0.00 |
| 86200 |
|
14 |
13 |
$0.00 |
| 80074 |
|
65 |
63 |
$0.00 |
| 90662 |
|
13 |
12 |
$0.00 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
53 |
26 |
$0.00 |
| 86038 |
|
14 |
13 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
61 |
43 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
19 |
15 |
$0.00 |
| 86900 |
|
12 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
25 |
14 |
$0.00 |
| 96367 |
|
19 |
13 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$0.00 |
| 72100 |
|
19 |
13 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
24 |
16 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14 |
13 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
16 |
14 |
$0.00 |